Benzinga's Top Initiations - Sphere 3D (NASDAQ:ANY)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Analysts at Barclays initiated coverage on Ariad Pharmaceuticals, Inc.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NASDAQ: ARIA) with a Underweight rating. The target price for Ariad Pharmaceuticals is set to $6. Ariad Pharmaceuticals shares closed at $5.42 on Friday.Chardan Capital initiated coverage on Ituran Location and Control Ltd. (US) (NASDAQ: ITRN) with a Buy rating. Ituran Location and Control shares closed at $17.20 on Friday. Analysts at Cowen & Companyinitiated coverage on Adamas Pharmaceuticals Inc (NASDAQ: ADMS) with a Outperform rating. The target price for Adamas Pharmaceuticals is set to $45. Adamas Pharmaceuticals shares closed at $25.01 on Friday. Analysts at RBC Capital initiated coverage of CSRA Inc (NYSE: CSRA) with a Outperform rating. CSRA shares closed at $28.42 on Friday.Analysts at Jefferies initiated coverage on

Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.

Horizon Pharma PLC

(NASDAQ: HZNP) with a Buy rating. . The target price for Horizon Pharma is set to $31. Horizon Pharma shares closed at $18.37 on Friday.Ladenburg Thalmann initiated coverage of Sphere 3D Corp. (NASDAQ: ANY) with a Buy rating. Sphere 3D shares closed at $1.13 on Friday.Mizuho Securities initiated coverage on Adamas Pharmaceuticals Inc (NASDAQ: ADMS) with a Neutral rating. The target price for Adamas Pharmaceuticals is set to $26. Adamas Pharmaceuticals shares closed at $25.01 on Friday.Analysts at Barclays initiated coverage on Novocure Ltd (NASDAQ: NVCR) with a Underweight rating. The target price for Novocure is set to $16. Novocure shares closed at $17.79 on Friday.Lake Street initiated coverage on Pure Storage Inc (NYSE: PSTG) with a Buy rating. The target price for Pure Storage is set to $20. Pure Storage shares closed at $13.94 on Friday.